Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quintuple therapy for COVID-19 infection
NCT04334512Phase 2Completed
- Sponsor
- ProgenaBiome
- Start
- Jun 2020
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by ProgenaBiome. Started Jun 2020; status: completed.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04334512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04334512.